- Home
- STAA vs EVT Comparison
STAA vs EVT Comparison
Compare STAA & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STAA | EVT |
|---|---|---|
| Founded | 1982 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STAA | EVT |
|---|---|---|
| Price | $23.93 | $24.76 |
| Analyst Decision | Hold | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $24.56 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 115.5K |
| Earning Date | 02-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 6.63 |
| Revenue | ★ $230,591,000.00 | $69,404,302.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.61 | N/A |
| P/E Ratio | ★ N/A | $3.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.50 | $19.20 |
| 52 Week High | $30.81 | $25.83 |
Technical Indicators
Market Signals| Indicator | STAA | EVT |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 59.88 |
| Support Level | $22.90 | $24.35 |
| Resistance Level | $26.18 | $24.88 |
| Average True Range (ATR) | 1.56 | 0.27 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 23.54 | 79.37 |
Price Performance
Historical ComparisonAbout STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.